Gene · 23600
Papers2,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic-based stratification of intermediate-risk prostate cancer patients. | Life Sci Alliance | 2024 | 38052461 | PubTator, text mining | PubMed |
| Intrahepatic cholangiocarcinoma initially diagnosed as adenocarcinoma of unknown primary with hepatoduodenal ligament lymph node metastases: A case report. | Oncol Lett | 2024 | 38028185 | PubTator, text mining | PubMed |
| Clinicopathological and molecular features of renal cell carcinomas with haemangioblastoma-like features distinct from clear cell renal cell carcinoma. | Histopathology | 2024 | 37988260 | PubTator, text mining | PubMed |
| Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations. | Cancer Res Treat | 2024 | 37697729 | PubTator, text mining | PubMed |
| Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2024 | 37634036 | PubTator, text mining | PubMed |
| Microbial diversity and metabolic inference of diclofenac removal in optimised batch heterotrophic-denitrifying conditions by means of factorial design. | Environ Technol | 2024 | 36927407 | PubTator, text mining | PubMed |
| Pleomorphic giant cell carcinoma of the prostate: A case report and mini‑review of the literature. | Med Int (Lond) | 2023 | 38222251 | PubTator, text mining | PubMed |
| Claudins in genitourinary tract neoplasms: mechanisms, prognosis, and therapeutic prospects. | Front Cell Dev Biol | 2023 | 38188015 | PubTator, text mining | PubMed |
| Mesenchymal-Epithelial Transition Kinase Inhibitor Therapy in Patients with Advanced Papillary Renal-Cell Carcinoma: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2023 | 38139411 | PubTator, text mining | PubMed |
| Gastro-Esophageal Junction Precancerosis: Histological Diagnostic Approach and Pathogenetic Insights. | Cancers (Basel) | 2023 | 38136271 | PubTator, text mining | PubMed |
| Scalp nodules as the first presentation of prostate cancer: A CARE-compliant article. | Medicine (Baltimore) | 2023 | 38115333 | PubTator, text mining | PubMed |
| Symphony in the crowd: Key genetic alterations in prostate cancer. | Cancer Innov | 2023 | 38089408 | PubTator, text mining | PubMed |
| Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials. | Front Oncol | 2023 | 38074675 | PubTator, text mining | PubMed |
| An Unusual Case of Metachronous Tumors of Prostate and Parotid Gland: A Diagnostic Dilemma. | Cureus | 2023 | 38074059 | PubTator, text mining | PubMed |
| Extragonadal Nongestational Choriocarcinoma With a Widespread Metastasis in a Young Female: A Case Report and Literature Analysis With a Focus on Unmet Needs. | Cureus | 2023 | 38074016 | PubTator, text mining | PubMed |
| Integrated Genomic Analysis of Primary Prostate Tumor Foci and Corresponding Lymph Node Metastases Identifies Mutations and Pathways Associated with Metastasis. | Cancers (Basel) | 2023 | 38067373 | PubTator, text mining | PubMed |
| Cytomorphology of papillary renal neoplasm with reverse polarity. | Cytojournal | 2023 | 38053633 | PubTator, text mining | PubMed |
| Identification of a 24-gene panel and a novel marker of PODXL2 essential for the pathological diagnosis of early prostate cancer. | Comput Struct Biotechnol J | 2023 | 38022698 | PubTator, text mining | PubMed |
| Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance. | Int J Mol Sci | 2023 | 38003213 | PubTator, text mining | PubMed |
| Intraductal Carcinoma of the Prostate: To Grade or Not to Grade. | Cancers (Basel) | 2023 | 38001579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23600/papers?page=8